Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2005

Open Access 01-09-2005 | Research article

Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens

Authors: Martin Schmidt, Claudia Weidler, Heidrun Naumann, Sven Anders, Jürgen Schölmerich, Rainer H Straub

Published in: Arthritis Research & Therapy | Issue 5/2005

Login to get access

Abstract

In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy with androgens in RA could be a problem. This study was carried out in order to compare conversion products of androgens in RA and OA synoviocytes. In 26 OA and 24 RA patients, androgen conversion in synovial cells was investigated using radiolabeled substrates and analysis by thin-layer chromatography and HPLC. Aromatase expression was studied by immunohistochemistry. Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16αOH-DHEA, 7αOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16αOH-testosterone (similar in OA and RA). Surprisingly, levels of E2, E3, and 16α-hydroxylated steroids were as high as levels of testosterone. In RA and OA, 5α-dihydrotestosterone increased conversion of DHEA into testosterone but not into estrogens. The second androgen, ASD, was converted into 5α-dihydro-ASD, testosterone, and negligible amounts of E1, E2, E3, or 16αOH-testosterone. 5α-dihydro-ASD levels were higher in RA than OA. The third androgen, testosterone, was converted into ASD, 5α-dihydro-ASD, 5α-dihydrotestosterone, and negligible quantities of E1 and E2. 5α-dihydrotestosterone was higher in RA than OA. ASD and testosterone nearly completely blocked aromatization of androgens. In addition, density of aromatase-positive cells and concentration of released E2, E3, and free testosterone from superfused synovial tissue was similar in RA and OA but estrogens were markedly higher than free testosterone. In conclusion, ASD and testosterone might be favorable anti-inflammatory compounds because they decrease aromatization and increase anti-inflammatory 5α-reduced androgens. In contrast, DHEA did not block aromatization but yielded high levels of estrogens and proproliferative 16α-hydroxylated steroids. Androgens were differentially converted to pro- and anti-inflammatory steroid hormones via diverse pathways.
Appendix
Available only for authorised users
Literature
1.
go back to reference Danenberg HD, Alpert G, Lustig S, Ben-Nathan D: Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother. 1992, 36: 2275-2279.PubMedCentralCrossRefPubMed Danenberg HD, Alpert G, Lustig S, Ben-Nathan D: Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother. 1992, 36: 2275-2279.PubMedCentralCrossRefPubMed
2.
go back to reference Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY: Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol. 1993, 150: 5219-5230.PubMed Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY: Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol. 1993, 150: 5219-5230.PubMed
3.
go back to reference Li ZG, Danis VA, Brooks PM: Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 1993, 11: 157-162.PubMed Li ZG, Danis VA, Brooks PM: Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 1993, 11: 157-162.PubMed
4.
go back to reference Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Balleari E, Bason C, Felli L, Granata OM, Amodio R, Castagnetta L: Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. Mediat Inflam. 1995, 4: 138-145.CrossRef Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Balleari E, Bason C, Felli L, Granata OM, Amodio R, Castagnetta L: Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. Mediat Inflam. 1995, 4: 138-145.CrossRef
5.
go back to reference Kanda N, Tsuchida T, Tamaki K: Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol. 1996, 106: 410-415. 10.1046/j.1365-2249.1996.d01-842.x.PubMedCentralCrossRefPubMed Kanda N, Tsuchida T, Tamaki K: Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol. 1996, 106: 410-415. 10.1046/j.1365-2249.1996.d01-842.x.PubMedCentralCrossRefPubMed
6.
go back to reference Kanda N, Tsuchida T, Tamaki K: Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1703-1711.CrossRefPubMed Kanda N, Tsuchida T, Tamaki K: Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1703-1711.CrossRefPubMed
7.
go back to reference Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, Falk W, Lang B: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro : possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab. 1998, 83: 2012-2017. 10.1210/jc.83.6.2012.CrossRefPubMed Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, Falk W, Lang B: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro : possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab. 1998, 83: 2012-2017. 10.1210/jc.83.6.2012.CrossRefPubMed
8.
go back to reference Keller ET, Chang C, Ershler WB: Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem. 1996, 271: 26267-26275. 10.1074/jbc.271.32.19042.CrossRefPubMed Keller ET, Chang C, Ershler WB: Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem. 1996, 271: 26267-26275. 10.1074/jbc.271.32.19042.CrossRefPubMed
9.
go back to reference Toyoda H, Takei S, Formby B: Effect of 5-alpha dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse. Proc Soc Exp Biol Med. 1996, 213: 287-293.CrossRefPubMed Toyoda H, Takei S, Formby B: Effect of 5-alpha dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse. Proc Soc Exp Biol Med. 1996, 213: 287-293.CrossRefPubMed
10.
go back to reference Cutolo M, Balleari E, Giusti M, Intra E, Accardo S: Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1-5.CrossRefPubMed Cutolo M, Balleari E, Giusti M, Intra E, Accardo S: Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1-5.CrossRefPubMed
11.
go back to reference Booji A, Biewenga-Booji CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW: Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 811-815.PubMedCentralCrossRefPubMed Booji A, Biewenga-Booji CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW: Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 811-815.PubMedCentralCrossRefPubMed
12.
go back to reference Milewich L, Kaimal V, Toews GB: Androstenedione metabolism in human alveolar macrophages. J Clin Endocrinol Metab. 1983, 56: 920-924.CrossRefPubMed Milewich L, Kaimal V, Toews GB: Androstenedione metabolism in human alveolar macrophages. J Clin Endocrinol Metab. 1983, 56: 920-924.CrossRefPubMed
13.
go back to reference Simpson ER: Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med. 2004, 22: 11-23. 10.1055/s-2004-823023.CrossRefPubMed Simpson ER: Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med. 2004, 22: 11-23. 10.1055/s-2004-823023.CrossRefPubMed
14.
go back to reference Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH: Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol. 2000, 164: 161-169. 10.1677/joe.0.1640161.CrossRefPubMed Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH: Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol. 2000, 164: 161-169. 10.1677/joe.0.1640161.CrossRefPubMed
15.
go back to reference Schmitt M, Klinga K, Schnarr B, Morfin R, Mayer D: Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Mol Cell Endocrinol. 2001, 173: 1-13. 10.1016/S0303-7207(00)00442-1.CrossRefPubMed Schmitt M, Klinga K, Schnarr B, Morfin R, Mayer D: Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Mol Cell Endocrinol. 2001, 173: 1-13. 10.1016/S0303-7207(00)00442-1.CrossRefPubMed
16.
go back to reference Ishida Y, Killinger DW, Khalil MW, Yang K, Strutt B, Heersche JN: Expression of steroid-converting enzymes in osteoblasts derived from rat vertebrae. Osteoporos Int. 2002, 13: 235-240. 10.1007/s001980200020.CrossRefPubMed Ishida Y, Killinger DW, Khalil MW, Yang K, Strutt B, Heersche JN: Expression of steroid-converting enzymes in osteoblasts derived from rat vertebrae. Osteoporos Int. 2002, 13: 235-240. 10.1007/s001980200020.CrossRefPubMed
17.
go back to reference Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH: Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 2597-2605.PubMed Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH: Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 2597-2605.PubMed
18.
go back to reference Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A: Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum. 2004, 50: 3346-3353. 10.1002/art.20509.CrossRefPubMed Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A: Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum. 2004, 50: 3346-3353. 10.1002/art.20509.CrossRefPubMed
19.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.CrossRefPubMed
20.
go back to reference Miller LE, Jüsten HP, Schölmerich J, Straub RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 2000, 14: 2097-2107. 10.1096/fj.99-1082com.CrossRefPubMed Miller LE, Jüsten HP, Schölmerich J, Straub RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 2000, 14: 2097-2107. 10.1096/fj.99-1082com.CrossRefPubMed
21.
go back to reference Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Schölmerich J, Straub RH: Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1156-1163. 10.1002/art.20110.CrossRefPubMed Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Schölmerich J, Straub RH: Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1156-1163. 10.1002/art.20110.CrossRefPubMed
22.
go back to reference Bresnihan B, Cunnane G, Youssef P, Yanni G, Fitzgerald O, Mulherin D: Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis. Br J Rheumatol. 1998, 37: 636-642. 10.1093/rheumatology/37.6.636.CrossRefPubMed Bresnihan B, Cunnane G, Youssef P, Yanni G, Fitzgerald O, Mulherin D: Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis. Br J Rheumatol. 1998, 37: 636-642. 10.1093/rheumatology/37.6.636.CrossRefPubMed
23.
go back to reference Giltay EJ, van Schaardenburg D, Gooren LJ, von Blomberg BM, Fonk JC, Touw DJ, Dijkmans BA: Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis. Br J Rheumatol. 1998, 37: 705-706. 10.1093/rheumatology/37.6.705.CrossRefPubMed Giltay EJ, van Schaardenburg D, Gooren LJ, von Blomberg BM, Fonk JC, Touw DJ, Dijkmans BA: Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis. Br J Rheumatol. 1998, 37: 705-706. 10.1093/rheumatology/37.6.705.CrossRefPubMed
24.
go back to reference Bourguiba S, Genissel C, Lambard S, Bouraima H, Carreau S: Regulation of aromatase gene expression in Leydig cells and germ cells. J Steroid Biochem Mol Biol. 2003, 86: 335-343. 10.1016/S0960-0760(03)00343-1.CrossRefPubMed Bourguiba S, Genissel C, Lambard S, Bouraima H, Carreau S: Regulation of aromatase gene expression in Leydig cells and germ cells. J Steroid Biochem Mol Biol. 2003, 86: 335-343. 10.1016/S0960-0760(03)00343-1.CrossRefPubMed
25.
go back to reference Berkovitz GD, Carter KM, Brown TR, Migeon CJ: Testosterone lowers aromatase activity in cultured human genital skin fibroblasts. Mol Cell Endocrinol. 1990, 69: 187-197. 10.1016/0303-7207(90)90012-W.CrossRefPubMed Berkovitz GD, Carter KM, Brown TR, Migeon CJ: Testosterone lowers aromatase activity in cultured human genital skin fibroblasts. Mol Cell Endocrinol. 1990, 69: 187-197. 10.1016/0303-7207(90)90012-W.CrossRefPubMed
26.
go back to reference Kirilovas D, Naessen T, Bergstrom M, Bonasera TA, Bergstrom-Pettermann E, Holte J, Carlstrom K, Simberg N, Langstrom B: Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro. Acta Obstet Gynecol Scand. 2003, 82: 209-215. 10.1034/j.1600-0412.2003.00144.x.PubMed Kirilovas D, Naessen T, Bergstrom M, Bonasera TA, Bergstrom-Pettermann E, Holte J, Carlstrom K, Simberg N, Langstrom B: Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro. Acta Obstet Gynecol Scand. 2003, 82: 209-215. 10.1034/j.1600-0412.2003.00144.x.PubMed
27.
go back to reference Greenspan FS, Gardner DG: Basic and Clinical Endocrinology. 2004, New York: Lange MedicalBooks/McGraw-Hill, Medical Pub. Division Greenspan FS, Gardner DG: Basic and Clinical Endocrinology. 2004, New York: Lange MedicalBooks/McGraw-Hill, Medical Pub. Division
28.
go back to reference Schneider J, Huh MM, Bradlow HL, Fishman J: Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem. 1984, 259: 4840-4845.PubMed Schneider J, Huh MM, Bradlow HL, Fishman J: Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem. 1984, 259: 4840-4845.PubMed
29.
go back to reference Swaneck GE, Fishman J: Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA. 1988, 85: 7831-7835.PubMedCentralCrossRefPubMed Swaneck GE, Fishman J: Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA. 1988, 85: 7831-7835.PubMedCentralCrossRefPubMed
30.
go back to reference Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL: Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 1992, 84: 634-638.CrossRefPubMed Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL: Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 1992, 84: 634-638.CrossRefPubMed
31.
go back to reference Weidler C, Härle P, Schedel J, Schmidt M, Schölmerich J, Straub RH: Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol. 2004, 31: 489-494.PubMed Weidler C, Härle P, Schedel J, Schmidt M, Schölmerich J, Straub RH: Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol. 2004, 31: 489-494.PubMed
32.
go back to reference Kanda N, Tamaki K: Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999, 103: 282-288.CrossRefPubMed Kanda N, Tamaki K: Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999, 103: 282-288.CrossRefPubMed
33.
go back to reference Kanda N, Tsuchida T, Tamaki K: Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999, 42: 328-337. 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#.CrossRefPubMed Kanda N, Tsuchida T, Tamaki K: Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999, 42: 328-337. 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#.CrossRefPubMed
34.
go back to reference Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223.CrossRefPubMed Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223.CrossRefPubMed
35.
go back to reference Straub RH, Besedovsky HO: Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J. 2003, 17: 2176-2183. 10.1096/fj.03-0433hyp.CrossRefPubMed Straub RH, Besedovsky HO: Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J. 2003, 17: 2176-2183. 10.1096/fj.03-0433hyp.CrossRefPubMed
Metadata
Title
Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
Authors
Martin Schmidt
Claudia Weidler
Heidrun Naumann
Sven Anders
Jürgen Schölmerich
Rainer H Straub
Publication date
01-09-2005
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1769

Other articles of this Issue 5/2005

Arthritis Research & Therapy 5/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.